FDA’s Speed vs. Science | Charlottesville News

The FDA’s drug approval process is under fire as pressure mounts to speed up approvals, sparking fears that rushing could undermine global trust in its scientific rigor. Balancing rapid access to life-saving treatments with the agency’s core mission of public safety is proving increasingly difficult, especially as international regulators begin to scrutinize US-approved drugs more closely. Scientists and advocates warn that compromising integrity for expediency could damage the FDA’s reputation—and have ripple effects on global health initiatives and medical innovation. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/853ec29263271580